Evidence map›Paper›PMID 38303537›Full record

ReviewCurrent drug research reviews2025

Emulgel: A Cutting Edge Approach for Topical Drug Delivery System.

Anjali Jain, Prashant Kumar, Anurag Verma, Bibhash Chandra Mohanta, Sumel Ashique, Radheshyam Pal, Shubneesh Kumar, Neeraj Mishra

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug research reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Polymers · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anjali JainTeerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University Moradabad Uttar Pradesh, 244001, India.
Prashant KumarTeerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University Moradabad Uttar Pradesh, 244001, India.
Anurag VermaTeerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University Moradabad Uttar Pradesh, 244001, India.
Bibhash Chandra MohantaDepartment of Pharmacy, Central University of South Bihar, Gaya, Bihar, 824236, India.
Sumel AshiqueDepartment of Pharmaceutical Science, Pandaveswar School of Pharmacy, Pandaveswar, West Bengal, 713378, India.ORCID 0000-0003-4362-2830
Radheshyam PalDepartment of Pharmaceutical Science, Pandaveswar School of Pharmacy, Pandaveswar, West Bengal, 713378, India.
Shubneesh KumarDepartment of Pharmaceutical Science, Bharat Institute of Technology (BIT), School of Pharmacy, Meerut, 250103, UP, India.
Neeraj MishraAmity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, 474005, MP, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emulgel is considered an advanced leading form of topical drug delivery system. It possesses the quality of a dual control drug mechanism for drug release as it holds the properties of both gel as well as emulsion. Emulgel is capable of overcoming the problems of the conventional route of topical drug delivery, like low spreadability and stickiness with the delivery of hydrophobic drugs, enhanced bioavailability at the local site of action, no greasy texture, and ensuring patient compliance. An emulsion is used either w/o or o/w, and the drug can be incorporated into the suitable phase of the emulsion. After that, the emulsion is incorporated into the gel phase. Several factors like oil phase, gelling agent, and emulsifier can affect the efficacy and stability. This advancement is beneficial not only for dermatology but also for cosmetology as well. Currently, emulgel-based formulations are used for the delivery of anti-inflammatory, analgesic, anti-acne, and antifungal drugs with a wide array of exploration.

Indexed as

Drug Delivery SystemsAdministration, CutaneousAdministration, TopicalAnimalsBiological AvailabilityEmulsionsGelsHumansEmulsionsGelsdrug delivery system.Emulgelemulsiongelskintopicaltopical permeation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.